Not Tagged
Not Tagged
['paradigm', 'rectal', 'prospect trial', 'colorectal']
prospect trial showing neoadjuvant chemo + selective chemort is non-inferior to chemort.
&lt; 2% local recurrence in both arms. path cr, r0 resection rates, os also all equivalent. wonder how to apply in current tnt and non-operative mgmt paradigm? #asco23 #colorectalcancer 
GI #Oncologist @ClevelandClinic | @USNews contributor | Tweets my own